3
Announcements
Trials
Browse
Landscape
Status
Completed
4
Withdrawn
1
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Carcinoma, Hepatocellular
6
Neoplasm Metastasis
5
Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Lung Neoplasms
2
Cholangiocarcinoma
2
Brain Neoplasms
2
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcopenia
1
Rectal Neoplasms
1
Radiation Pneumonitis
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Objective Response Rate
1
Neoplasm, Residual
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Locally Advanced Non-small Cell Lung Cancer
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Deglutition Disorders
1
Colorectal Neoplasms
1
Interventions
Cisplatin
28
Radiotherapy
20
pembrolizumab
9
Paclitaxel
9
Surveys and Questionnaires
8
Cetuximab
8
Fluorouracil
7
Docetaxel
7
Radiotherapy, Intensity-Modulated
6
Carboplatin
6
apatinib
5
Low-Level Light Therapy
5
Blood Specimen Collection
5
durvalumab
4
Standard of Care
4
Magnetic Resonance Imaging
4
Gemcitabine
4
Cyclophosphamide
4
Celecoxib
4
Tegafur
3
Radiation
3
Oncolytic Virotherapy
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Lidocaine
3
Immunoenzyme Techniques
3
Drug Therapy
3
Chemotherapy, Adjuvant
3
Biopsy
3
toripalimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Head and Neck Neoplasms
×
Immunotherapy
×
Clear all
NCT04359199
2023-02-10
QUASAR
University of California, San Diego
Unknown
42 enrolled